Company Description
Evio (OTC Link: EVIO) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.8M.
EVIO stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of EVIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Evio (EVIO) stock last traded at $0.0000. At a market capitalization of $1.8M, EVIO is classified as a micro-cap stock with approximately 19.2B shares outstanding.
Latest News
Evio has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include partnership, crypto. View all EVIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EVIO Company Profile & Sector Positioning
Evio (EVIO) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EVIO often look at related companies in the same sector, including STEMTECH CORPORATION (STEK), Aion Therapeutic (ANTCF), Sibannac (SNNC), Choom Hldgs (CHOOF), and Flower One Hldgs Inc (FLOOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EVIO's relative position within its industry.